Study To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects
Clinical trial NCT05701644 · COMPLETED
Trial details
- NCT number
- NCT05701644
- Sponsor
- Ensol Bioscience
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-02
- Primary completion
- 2023-06-28
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.